Malignant astrocytic glioma: Genetics, biology, and paths to treatment

Frank B. Furnari, Tim Fenton, Robert M. Bachoo, Akitake Mukasa, Jayne M. Stommel, Alexander Stegh, William C. Hahn, Keith L. Ligon, David N. Louis, Cameron Brennan, Lynda Chin, Ronald A. DePinho*, Webster K. Cavenee

*Corresponding author for this work

Research output: Contribution to journalReview article

1487 Citations (Scopus)

Abstract

Malignant astrocytic gliomas such as glioblastoma are the most common and lethal intracranial tumors. These cancers exhibit a relentless malignant progression characterized by widespread invasion throughout the brain, resistance to traditional and newer targeted therapeutic approaches, destruction of normal brain tissue, and certain death. The recent confluence of advances in stem cell biology, cell signaling, genome and computational science and genetic model systems have revolutionized our understanding of the mechanisms underlying the genetics, biology and clinical behavior of glioblastoma. This progress is fueling new opportunities for understanding the fundamental basis for development of this devastating disease and also novel therapies that, for the first time, portend meaningful clinical responses.

Original languageEnglish (US)
Pages (from-to)2683-2710
Number of pages28
JournalGenes and Development
Volume21
Issue number21
DOIs
StatePublished - Nov 1 2007

Fingerprint

Astrocytoma
Glioblastoma
Glioma
Genetic Models
Brain
Cell Biology
Neoplasms
Stem Cells
Genome
Therapeutics

Keywords

  • Cancer stem cells
  • Genetically engineered models
  • Glioblastoma
  • Glioma
  • Neural stem cells
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., ... Cavenee, W. K. (2007). Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes and Development, 21(21), 2683-2710. https://doi.org/10.1101/gad.1596707
Furnari, Frank B. ; Fenton, Tim ; Bachoo, Robert M. ; Mukasa, Akitake ; Stommel, Jayne M. ; Stegh, Alexander ; Hahn, William C. ; Ligon, Keith L. ; Louis, David N. ; Brennan, Cameron ; Chin, Lynda ; DePinho, Ronald A. ; Cavenee, Webster K. / Malignant astrocytic glioma : Genetics, biology, and paths to treatment. In: Genes and Development. 2007 ; Vol. 21, No. 21. pp. 2683-2710.
@article{415a007fbe644a60865d7739e8599d5c,
title = "Malignant astrocytic glioma: Genetics, biology, and paths to treatment",
abstract = "Malignant astrocytic gliomas such as glioblastoma are the most common and lethal intracranial tumors. These cancers exhibit a relentless malignant progression characterized by widespread invasion throughout the brain, resistance to traditional and newer targeted therapeutic approaches, destruction of normal brain tissue, and certain death. The recent confluence of advances in stem cell biology, cell signaling, genome and computational science and genetic model systems have revolutionized our understanding of the mechanisms underlying the genetics, biology and clinical behavior of glioblastoma. This progress is fueling new opportunities for understanding the fundamental basis for development of this devastating disease and also novel therapies that, for the first time, portend meaningful clinical responses.",
keywords = "Cancer stem cells, Genetically engineered models, Glioblastoma, Glioma, Neural stem cells, Tyrosine kinase inhibitor",
author = "Furnari, {Frank B.} and Tim Fenton and Bachoo, {Robert M.} and Akitake Mukasa and Stommel, {Jayne M.} and Alexander Stegh and Hahn, {William C.} and Ligon, {Keith L.} and Louis, {David N.} and Cameron Brennan and Lynda Chin and DePinho, {Ronald A.} and Cavenee, {Webster K.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1101/gad.1596707",
language = "English (US)",
volume = "21",
pages = "2683--2710",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "21",

}

Furnari, FB, Fenton, T, Bachoo, RM, Mukasa, A, Stommel, JM, Stegh, A, Hahn, WC, Ligon, KL, Louis, DN, Brennan, C, Chin, L, DePinho, RA & Cavenee, WK 2007, 'Malignant astrocytic glioma: Genetics, biology, and paths to treatment', Genes and Development, vol. 21, no. 21, pp. 2683-2710. https://doi.org/10.1101/gad.1596707

Malignant astrocytic glioma : Genetics, biology, and paths to treatment. / Furnari, Frank B.; Fenton, Tim; Bachoo, Robert M.; Mukasa, Akitake; Stommel, Jayne M.; Stegh, Alexander; Hahn, William C.; Ligon, Keith L.; Louis, David N.; Brennan, Cameron; Chin, Lynda; DePinho, Ronald A.; Cavenee, Webster K.

In: Genes and Development, Vol. 21, No. 21, 01.11.2007, p. 2683-2710.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Malignant astrocytic glioma

T2 - Genetics, biology, and paths to treatment

AU - Furnari, Frank B.

AU - Fenton, Tim

AU - Bachoo, Robert M.

AU - Mukasa, Akitake

AU - Stommel, Jayne M.

AU - Stegh, Alexander

AU - Hahn, William C.

AU - Ligon, Keith L.

AU - Louis, David N.

AU - Brennan, Cameron

AU - Chin, Lynda

AU - DePinho, Ronald A.

AU - Cavenee, Webster K.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Malignant astrocytic gliomas such as glioblastoma are the most common and lethal intracranial tumors. These cancers exhibit a relentless malignant progression characterized by widespread invasion throughout the brain, resistance to traditional and newer targeted therapeutic approaches, destruction of normal brain tissue, and certain death. The recent confluence of advances in stem cell biology, cell signaling, genome and computational science and genetic model systems have revolutionized our understanding of the mechanisms underlying the genetics, biology and clinical behavior of glioblastoma. This progress is fueling new opportunities for understanding the fundamental basis for development of this devastating disease and also novel therapies that, for the first time, portend meaningful clinical responses.

AB - Malignant astrocytic gliomas such as glioblastoma are the most common and lethal intracranial tumors. These cancers exhibit a relentless malignant progression characterized by widespread invasion throughout the brain, resistance to traditional and newer targeted therapeutic approaches, destruction of normal brain tissue, and certain death. The recent confluence of advances in stem cell biology, cell signaling, genome and computational science and genetic model systems have revolutionized our understanding of the mechanisms underlying the genetics, biology and clinical behavior of glioblastoma. This progress is fueling new opportunities for understanding the fundamental basis for development of this devastating disease and also novel therapies that, for the first time, portend meaningful clinical responses.

KW - Cancer stem cells

KW - Genetically engineered models

KW - Glioblastoma

KW - Glioma

KW - Neural stem cells

KW - Tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=35949002429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35949002429&partnerID=8YFLogxK

U2 - 10.1101/gad.1596707

DO - 10.1101/gad.1596707

M3 - Review article

C2 - 17974913

AN - SCOPUS:35949002429

VL - 21

SP - 2683

EP - 2710

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 21

ER -

Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A et al. Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes and Development. 2007 Nov 1;21(21):2683-2710. https://doi.org/10.1101/gad.1596707